United States Pharmacopeia Safety Evaluation of Spirulina
The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Abstract
The Dietary Supplements Information Expert Committee (DSI-EC) of the United States Pharmacopeial Convention (USP) reviews the safety of dietary supplements and dietary supplement ingredients for the purpose of determining whether they should be admitted as quality monographs into the United States Pharmacopeia and National Formulary (USP-NF). The United States Food and Drug Administration (FDA) has enforcement authority to pursue a misbranding action in those instances where a dietary supplement product indicates that it conforms to USP standards but fails to so conform. Recently DSI-EC undertook a safety evaluation of spirulina, a widely used dietary ingredient. DSI-EC reviewed information from human clinical trials, animal studies, and regulatory and pharmacopeial sources and analyzed 31 adverse event reports regarding spirulina to assess potential health concerns. At the conclusion of this review, DSI-EC assigned a Class A safety rating for Spirulina maxima and S. platensis, thereby permitting the admission of quality monographs for these dietary supplement ingredients in USP-NF. DSI-EC continually monitors reports concerning the safety of dietary supplements and dietary supplement ingredients for which USP dietary supplement monographs are developed. The DSI-EC may revisit the safety classification of spirulina as new information on this dietary ingredient becomes available.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and its safety as a dietary supplement has been confirmed by the United States Pharmacopeia [54].”
From Valorization of Microalgae as Multifunctional Protein Sources in Plant-Based Systems: Structural, Functional, and Processing Challenges (2026) · cites this paper as [54]
In the citing paper
“Studies conducted on Spirulina suggest that it is safe in healthy subjects”
From Antioxidant, Immunomodulating, and Microbial‐Modulating Activities of the Sustainable and Ecofriendly Spirulina (2017) · cites this paper as [114]
In the citing paper
“The Food and Drug Administration (FDA) has categorized Arthrospira products as “generally recognized as safe” (GRAS) for human consumption and the Dietary Supplements Information Expert Committee (DSI-EC) concluded that there is not a serious risk to health with consumption of Spirulina [114].”
From Antioxidant, Immunomodulating, and Microbial‐Modulating Activities of the Sustainable and Ecofriendly Spirulina (2017) · cites this paper as [114]
In the citing paper
“Reported side effects associated with Spirulina consumption are insomnia and gastric problems with uncertain or unlikely causality [114]”
From Antioxidant, Immunomodulating, and Microbial‐Modulating Activities of the Sustainable and Ecofriendly Spirulina (2017) · cites this paper as [114]
In the citing paper
“Moreover, the Dietary Supplements Information Expert Committee (DSI-EC) of the United States Pharmacopeial Convention (USP) granted ‘Class A’ to Spirulina after rigorous analysis of clinical case reports, animal toxicological data and adverse event reports, thus making it safe for human consumption [6] when grown under controlled conditions [4,7].”
From Beneficial Effects of Spirulina Consumption on Brain Health (2022) · cites this paper as [6]
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914 · cited 1×
“DSI-EC observed that only a weak causality (possible rating) could be attributed to most AERs according to the WHO causality scale (WHO, 2004) or the Naranjo scale (Naranjo et al., 1981).”
MethodToxic Cyanobacteria in Water: A guide to their public health consequences, monitoring and management
(1999) · Taylor & Francis eBooks · doi:10.4324/9780203478073 · Cited by 1,553
Drugs in Pregnancy and Lactation
(1990) · Annals of Internal Medicine · doi:10.7326/0003-4819-113-11-902_3 · Cited by 1,075
If Nothing Goes Wrong, Is Everything All Right?: Interpreting Zero Numerators
Hanley, J. A. (1983) · JAMA · doi:10.1001/jama.1983.03330370053031 · Cited by 1,043 · cited 1×
“Eight cases of hepatotoxicity were associated with use of spirulina products, including 1 case report by Iwasa et al. (1982) (with concurrent simvastatin use), 5 MedWatch case reports (including case #15515 involving significant prior medical history, and case #67512 involving a multi-ingredient product), and 2 case r…”
BackgroundSpirulina, the edible microorganism.
Ciferri, O. (1983) · Microbiological Reviews · doi:10.1128/mmbr.47.4.551-578.1983 · Cited by 745 · cited 4×
“Although historical accounts (Ciferri, 1983) indicate consumption of spirulina (as Dihé in Africa) at 10 to 40 g, the contemporary typical intake of spirulina is 1–5 g daily before meals (Fetrow and Avila, 1999; NLM, 2009; Gilroy et al.”
BackgroundMethodInfluentialDiverse taxa of cyanobacteria produce β- N -methylamino- l -alanine, a neurotoxic amino acid
Cox, P. A., Banack, S. A., Murch, S. J., Rasmussen, U., Tien, G., Bidigare, R. R., Metcalf, J. S., Morrison, L. F., Codd, G. A., & Bergman, B. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501526102 · Cited by 707 · cited 1×
“(2005) reported isolation of neurotoxic β- N -methylamino- L -alanine (BMAA) from 77% of the Cyanobacteria tested, but the study did not include spirulina.”
BackgroundAntioxidant and anti-inflammatory properties of C-phycocyanin from blue-green algae
Romay, C., Armesto, J., Remirez, D., González, R., Ledon, N., & García, I. (1998) · Inflammation Research · doi:10.1007/s000110050256 · Cited by 511 · cited 1×
“Phycocyanin is the most abundant protein-bound pigment in Cyanobacteria and accounts for more than 20% of its dry weight (Romay et al., 1998).”
BackgroundBronstein, A. C., Spyker, D. A., Cantilena, L. R., Green, J. L., Rumack, B. H., & Giffin, S. L. (2009) · Clinical Toxicology · doi:10.3109/15563650903438566 · Cited by 485
Drugs in Pregnancy and Lactation
BRIGGS, G. G., FREEMAN, R. K., & YAFFE, S. J. (1987) · MCN, The American Journal of Maternal/Child Nursing · doi:10.1097/00005721-198711000-00013 · Cited by 386
Dietrich, D., & Hoeger, S. (2005) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2004.09.005 · Cited by 360 · cited 1×
“Several useful reviews of cyanobacterial toxins are available (Health Canada, 2008a; Purdue, 2007; Dietrich and Hoeger, 2005; Schaffer et al., 1999).”
Background
Research works printed but not linked: 33
- Atwater J. B., 2003, Regul. Aff. Focus, 42
- Atwater J. B., 2005, U.S. Pharmacist., 30, 61
- Băiuş C., 2002, Rom. J. Intern. Med, 40, 89
- Blumenthal M., 2000, Commission E Monographs
- Brinker F., 2001, Herb Contraindications and Drug Interaction, 3rd Ed.
- Chamorro G., 1996, Toxicol. Lett., 88, 67
- Chamorro G., 1996, Rev. Invest. Clin, 48, 389
- 2009, Canada Vigilance Adverse Reaction Online Database
- 2009, Dietary Supplements Labels Database
- 1995, ICH Topic E2A: Clinical Safety Data Management: Definitions and Standards for Expedited Reporting
- 2003, Agency Response Letter GRAS Notice No. GRN 000127
- 2007, Toxicological Principles for the Safety Assessment of Food Ingredients.
- 10.1001/jama.249.13.1743 · doi:10.1001/jama.249.13.1743 · Paper page
- 2008, Cyanobacterial Toxins: Microcystin-LR
- 2005, Dietary Supplements: A Framework for Evaluating Safety
- 10.1111/j.1572-0241.2002.07145.x · doi:10.1111/j.1572-0241.2002.07145.x · Paper page
- Johnson P. E., 1986, Nutr. Rep. Int., 34, 1063
- Karkos P. D., 2008, Evid. Based Complement. Alternat. Med.
- McGuffin M, 2000, Herbs of Commerce, 2nd Edition.
- 2009, Medicines and Healthcare products Regulatory Agency, UK
- 2009, Nutrition Business Journal; Raw material and ingredient supply report
- Taxonomy Browser
- 2009, National Library of Medicine. Medline Plus herbs and supplements—spirulina
- 2008, Chemical information review document for L-b-methylaminoalanine. Supporting nomination for toxicological evaluation by the National Toxicology Program
- 2001, Office of Inspector General Report: Adverse event reporting for dietary supplements: An inadequate safety valve
- 2008, Parry Nutraceuticals (India). Organic spirulina
- PubMed Database (available athttp://www.ncbi.nlm.nih.gov/sites/entrez?db=pubmed) (accessed 22 October 2009).
- 2007, Cyanosite
- Richmond A., 1999, J. Applied Physiol., 4, 281
- 2005, Therapeutic Goods Administration, Australia
- 2009, Admission Criteria and Safety Classification for Dietary Supplements Guideline
- 2004, World Health Organization Guidelines on Safety Monitoring of Herbal Medicines in Pharmacovigilance Systems
- Yamani E., 2009, Med. Trop. (Mars)., 69, 66
Cited by
The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview
Wu, Q., Liu, L., Miron, A., Klímová, B., Wan, D., & Kuča, K. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1744-5 · Cited by 655
van der Spiegel, M., Noordam, M. Y., & van der Fels‐Klerx, H. J. (2013) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12032 · Cited by 537
Finamore, A., Palmery, M., Bensehaila, S., & Peluso, I. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/3247528 · Cited by 256
“that there is not a serious risk to health with consumption of Spirulina [114].”
BackgroundGrosshagauer, S., Kraemer, K., & Somoza, V. (2020) · Journal of agricultural and food chemistry · doi:10.1021/acs.jafc.9b08251 · Cited by 216
Microalgae for Human and Animal Nutrition
Becker, E. W. (2013) · Handbook of Microalgal Culture · doi:10.1002/9781118567166.ch25 · Cited by 186
Metadata
- Authors
- Marles, R. J., Barrett, M. L., Barnes, J., Chavez, M. L., Gardiner, P., Ko, R., Mahady, G. B., Dog, T. L., Sarma, N. D., Giancaspro, G. I., Sharaf, M., & Griffiths, J.
- Affiliations
- United States Pharmacopeial Convention (US)
- ORCID
- Venue
- Critical Reviews in Food Science and Nutrition
- Publisher
- Informa UK Limited
- Published
- 2011-08
- Volume
- 51
- Issue
- 7
- Pages
- 593-604
- ISSN
- 1040-8398 (ISSN-L)
- 1549-7852
- OpenAlex
- W2004467604
- Semantic Scholar
- 56a8718e79e90d5453c8ee84cdea83bff94e4119
- Cited by
- 177
- References
- 71
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 23 · 2023: 13 · 2022: 35 · 2021: 14 · 2020: 9 · 2019: 11 · 2018: 11 · 2017: 10 · 2016: 4 · 2015: 10 · 2014: 5 · 2013: 5 · 2012: 3
- FWCI
- 12.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Food Science and Nutrition (publishedVersion)
- PubMed (publishedVersion)
- The Journal of the American Medical Association (JAMA) Network (American Medical Association) (submittedVersion)
- Funders
- Purdue University
- Topics
- Health Sciences › Medicine › Complementary and alternative medicine › Complementary and Alternative Medicine Studies
- Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Seaweed-derived Bioactive Compounds
- Life Sciences › Agricultural and Biological Sciences › Plant Science › Phytochemistry Medicinal Plant Applications
- Keywords
- Spirulina, Spirulina maxima, Spirulina platensis, supplement safety, adverse event reports, safety classification, misbranding, cyanobacteria
- MeSH terms
- Clinical Trials as Topic, Drug Evaluation, Drug Interactions, Humans, United States, United States Food and Drug Administration, Adverse Drug Reaction Reporting Systems, Guidelines as Topic, Metals, Heavy, Dietary Supplements, Microcystins, Spirulina
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: United States Pharmacopeia Safety Evaluation of Spirulina. https://app.cochat.ai/papers/10.1080/10408391003721719
- The paper
- Marles, R. J., Barrett, M. L., Barnes, J., Chavez, M. L., Gardiner, P., Ko, R., Mahady, G. B., Dog, T. L., Sarma, N. D., Giancaspro, G. I., Sharaf, M., & Griffiths, J. (2011). United States Pharmacopeia Safety Evaluation of Spirulina. Critical Reviews in Food Science and Nutrition. https://doi.org/10.1080/10408391003721719
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.